COLLPLANT HOLDI/S (CLGN) versus Its Rivals Critical Contrast

Share on StockTwits

COLLPLANT HOLDI/S (NASDAQ: CLGN) is one of 27 public companies in the “Surgical appliances & supplies” industry, but how does it contrast to its competitors? We will compare COLLPLANT HOLDI/S to similar businesses based on the strength of its institutional ownership, analyst recommendations, risk, profitability, earnings, dividends and valuation.

Institutional & Insider Ownership

58.0% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 10.3% of shares of all “Surgical appliances & supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for COLLPLANT HOLDI/S and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
COLLPLANT HOLDI/S 0 0 0 0 N/A
COLLPLANT HOLDI/S Competitors 175 823 1452 73 2.56

As a group, “Surgical appliances & supplies” companies have a potential upside of 18.77%. Given COLLPLANT HOLDI/S’s competitors higher probable upside, analysts clearly believe COLLPLANT HOLDI/S has less favorable growth aspects than its competitors.

Profitability

This table compares COLLPLANT HOLDI/S and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
COLLPLANT HOLDI/S -552.97% -80.17% -41.81%
COLLPLANT HOLDI/S Competitors -154.96% -220.52% -23.54%

Valuation & Earnings

This table compares COLLPLANT HOLDI/S and its competitors gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
COLLPLANT HOLDI/S $480,000.00 -$6.02 million -2.49
COLLPLANT HOLDI/S Competitors $1.39 billion $210.14 million 21.35

COLLPLANT HOLDI/S’s competitors have higher revenue and earnings than COLLPLANT HOLDI/S. COLLPLANT HOLDI/S is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

COLLPLANT HOLDI/S competitors beat COLLPLANT HOLDI/S on 8 of the 9 factors compared.

About COLLPLANT HOLDI/S

CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen (rhCollagen) that is produced with its proprietary plant based genetic engineering technology. The company's products include Vergenix STR, a soft tissue repair matrix intended for treatment of tendinopathy; Vergenix FG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd. and is headquartered in Ness Ziona, Israel.

Receive News & Ratings for COLLPLANT HOLDI/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COLLPLANT HOLDI/S and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.